# Obesity in Pregnancy

## Definitions and Epidemiology

### BMI Classification

Body mass index classifications relevant to obstetric care include overweight (BMI 25.0 to 29.9 kg/m2), obesity class I (BMI 30.0 to 34.9 kg/m2), obesity class II (BMI 35.0 to 39.9 kg/m2), obesity class III or severe/morbid obesity (BMI 40.0 kg/m2 or greater), and super obesity (BMI 50.0 kg/m2 or greater).

### Prevalence

Approximately 30 to 40% of reproductive-age women in the United States are obese, making obesity the most common medical condition encountered in pregnancy. The prevalence continues to rise across all demographic groups.

## Obstetric Complications

### Antepartum

Obesity substantially increases the risk of virtually every antepartum complication. Gestational diabetes occurs at 2 to 4 times the baseline rate. Preeclampsia risk increases 2 to 3 fold, with the risk escalating with each BMI class. Chronic hypertension is significantly more prevalent. Obstructive sleep apnea should be screened for and treated, as it is associated with adverse outcomes. Venous thromboembolism risk increases 2 to 5 fold. Spontaneous abortion and recurrent pregnancy loss are more common. Congenital anomalies, particularly neural tube defects (1.5 to 3.5 times increased risk), cardiac defects, and omphalocele, occur at higher rates independent of diabetes. Ultrasound imaging is more difficult because adipose tissue degrades image quality. Macrosomia and large for gestational age are more frequent.

### Intrapartum

Intrapartum complications include a higher rate of failed induction of labor, with some evidence that higher Bishop score thresholds may be needed. Labor dystocia is more common, with a prolonged first stage and slower cervical dilation. Shoulder dystocia and cesarean delivery rates increase substantially, with cesarean rates reaching up to 50% in class III obesity. Anesthetic challenges are significant, and difficulty with external fetal heart rate monitoring may necessitate internal monitoring.

### Postpartum

Postpartum complications include hemorrhage, wound complications (infection, dehiscence, and seroma), venous thromboembolism, postpartum depression, breastfeeding difficulties (delayed lactogenesis II), and longer hospital stays.

<image>Infographic showing the cascade of obesity-related obstetric risks organized by trimester, including antepartum complications (GDM, preeclampsia, anomalies), intrapartum complications (dystocia, cesarean, anesthetic challenges), and postpartum complications (wound infection, VTE, hemorrhage)</image>

## Weight Gain Recommendations

### IOM Guidelines by Pre-Pregnancy BMI

The Institute of Medicine (IOM) weight gain guidelines recommend 28 to 40 pounds for underweight women (BMI below 18.5), 25 to 35 pounds for normal weight women (BMI 18.5 to 24.9), 15 to 25 pounds for overweight women (BMI 25.0 to 29.9), and 11 to 20 pounds for obese women (BMI 30.0 or greater). No specific guidelines exist for class II or III obesity, though some experts recommend 5 to 15 pounds or weight maintenance. Excessive weight gain is associated with macrosomia, cesarean delivery, and postpartum weight retention. Weight loss during pregnancy is not recommended, but it may occur in severely obese patients without adverse effects.

| Pre-Pregnancy BMI | Category | Recommended Weight Gain |
|---|---|---|
| <18.5 | Underweight | 28-40 lbs |
| 18.5-24.9 | Normal weight | 25-35 lbs |
| 25.0-29.9 | Overweight | 15-25 lbs |
| ≥30.0 | Obese (all classes) | 11-20 lbs |
| ≥40.0 | Class III (expert opinion) | 5-15 lbs or weight maintenance |

## Prenatal Care Modifications

### First Trimester

An accurate dating ultrasound should be performed, and an earlier scan may be needed because ultrasound imaging becomes increasingly difficult as pregnancy progresses. Standard folic acid supplementation of 0.4 to 0.8 mg is given (4 mg if there is a prior neural tube defect). Baseline laboratory testing should include hemoglobin A1C to screen for preexisting diabetes. Low-dose aspirin at 81 mg should be started at 12 to 16 weeks because obesity is a risk factor for preeclampsia.

### Second/Third Trimester

Early gestational diabetes screening should be performed if risk factors are present, with repeat screening at 24 to 28 weeks if the initial screen is negative. A detailed anatomy survey may require a repeat scan or MRI for suboptimal views. Serial growth ultrasound is recommended for patients with a BMI of 40 or greater because clinical assessment of fundal height is unreliable. Antenatal testing beginning at 37 weeks should be considered for class III obesity, though this is institution-dependent.

### Nutrition and Exercise

Referral to a registered dietitian is recommended. A calorie-controlled diet appropriate for the patient's BMI should be prescribed, along with 150 minutes of moderate-intensity exercise per week (walking, swimming). Behavioral counseling for weight management is an important component of care.

## Medication Dosing Adjustments

### Antibiotics

Cefazolin dosing for cesarean surgical prophylaxis should be adjusted to body weight: 2 g for patients under 120 kg and 3 g for patients at or above 120 kg. Weight-based dosing should be considered for gentamicin, using ideal body weight plus 0.4 times the excess weight.

### Magnesium Sulfate

The standard loading dose of 4 to 6 g is appropriate regardless of weight. The maintenance dose may require adjustment, and magnesium levels should be monitored more closely. The larger volume of distribution in obese patients may delay achievement of therapeutic levels.

### Anticoagulation

Enoxaparin requires weight-based dosing for treatment. Prophylactic doses may also need adjustment: 40 mg daily for patients under 100 kg and 40 mg twice daily for patients at or above 100 kg (some centers use 0.5 mg/kg daily). Anti-Xa levels should be checked to confirm therapeutic dosing.

### Oxytocin

Standard induction protocols apply, and no specific dose adjustment is made for BMI. However, higher total doses may be needed, and prolonged inductions are more common.

### Analgesia

Acetaminophen and NSAIDs are dosed at standard levels. Opioids are given at standard doses, but excess should be avoided because of the increased risk of respiratory depression in patients with obstructive sleep apnea.

## Anesthetic Considerations

Early anesthesia consultation is recommended, ideally during the antepartum period for patients with class II or III obesity. Epidural and spinal placement is technically more difficult with a higher failure rate; ultrasound-guided neuraxial placement may improve success. The epidural should be placed early in labor to avoid the need for emergent general anesthesia, which carries the highest risk in this population. General anesthesia poses increased risks of difficult intubation, aspiration, and failed airway. Airway assessment should be performed at a prenatal visit, and Mallampati class is often higher in obese patients. Positioning may require a specialized operating table, as standard tables have a weight limit of approximately 450 pounds. Supine hypotension syndrome is exacerbated by the additional weight, making left lateral tilt essential.

<image>Diagram showing anesthetic challenges in the obese parturient, including difficult epidural placement due to increased skin-to-epidural space distance, airway management considerations with short neck and large tongue, and positioning requirements with left lateral tilt and specialized table</image>

## Surgical Considerations for Cesarean Delivery

### Incision Selection

A Pfannenstiel incision is preferred when technically feasible. A supraumbilical vertical midline incision may be necessary for super obesity or when the panniculus covers the Pfannenstiel site. Cephalad retraction of the panniculus with taping improves surgical access. Incisions within the pannus fold should be avoided because of the high infection rate associated with moisture and poor perfusion in that location.

### Intraoperative

Adequate exposure is achieved with self-retaining retractors, and extended instruments may be needed. Higher blood loss should be anticipated, and adequate intravenous access and blood availability are ensured. The risk of bowel and bladder injury is increased due to limited visualization.

### Wound Management

A subcutaneous drain should be considered if the subcutaneous tissue depth exceeds 2 cm (some centers use a threshold of 4 cm). Subcutaneous tissue should be closed with sutures when the fat layer is 2 cm or deeper, as this reduces wound complications. Prophylactic negative pressure wound therapy (wound VAC) on the closed incision reduces surgical site infection in obese patients, with evidence supporting its use for patients with a BMI of 40 or greater. Subcuticular closure may reduce wound complications compared to staples.

### Postoperative

Early mobilization is essential for DVT prevention. Incentive spirometry helps prevent atelectasis. Some institutions administer extended antibiotic prophylaxis for 24 to 48 hours after cesarean delivery in obese patients. Wound checks should be performed at 1 to 2 weeks postpartum.

## VTE Prophylaxis

### Risk Assessment

Obesity is an independent risk factor for venous thromboembolism in pregnancy and the postpartum period. Additional risk factors, including cesarean delivery, prolonged immobilization, preeclampsia, and prior VTE, compound the risk. ACOG and RCOG guidelines differ on the thresholds for pharmacologic prophylaxis.

### Recommendations

All obese patients after cesarean delivery should receive sequential compression devices intraoperatively and postpartum. For patients with a BMI of 40 or greater after cesarean delivery, pharmacologic prophylaxis with enoxaparin should be considered for 6 weeks postpartum. When additional risk factors are present alongside a BMI of 40 or greater, extended thromboprophylaxis is strongly recommended. For patients with a BMI of 40 or greater after vaginal delivery, the decision is individualized based on additional risk factors.

## Postpartum Considerations

### Breastfeeding Support

Delayed lactogenesis II is more common in obese patients, typically by 2 to 3 days. Early lactation support should be provided, and premature supplementation with formula should be avoided. Positioning assistance may be needed.

### Contraception

Long-acting reversible contraception (IUD and implant) is effective and recommended. Combined hormonal contraception carries increased VTE risk that is compounded by obesity and should be used with caution. Progestin-only methods are safe. Data on whether contraceptive efficacy of oral methods is reduced with higher BMI are limited.

### Weight Management

Postpartum weight retention is common. Counseling about weight loss goals between pregnancies is important. Bariatric surgery referral should be offered to appropriate candidates, with the recommendation to delay pregnancy 12 to 24 months after surgery and to monitor for nutritional deficiencies.

## Clinical Pearls

Obesity is the most common comorbidity in pregnancy and complicates nearly every aspect of obstetric care.

Low-dose aspirin should be started at 12 to 16 weeks for all obese patients for preeclampsia prevention.

The epidural should be placed early in labor. Emergent general anesthesia in an obese patient is the highest-risk scenario.

Cefazolin dose for cesarean prophylaxis increases to 3 g for patients weighing 120 kg or more.

Prophylactic negative pressure wound therapy reduces surgical site infection after cesarean in patients with a BMI of 40 or greater.

Weight-based enoxaparin dosing is critical because standard prophylactic doses may be subtherapeutic.

Congenital anomaly screening is more difficult due to poor ultrasound visualization. Plan for early and repeat imaging.

Counsel patients about IOM weight gain targets. Limiting excessive weight gain improves outcomes even if the starting BMI is high.

## References

- ACOG Practice Bulletin No. 230: Obesity in Pregnancy (2021)
- ACOG Committee Opinion No. 804: Physical Activity and Exercise During Pregnancy (2020)
- Smid MC et al. Maternal super obesity and neonatal morbidity. Am J Obstet Gynecol. 2021
- Stamilio DM et al. Weight-based dosing of cefazolin for cesarean prophylaxis. Obstet Gynecol. 2006
- Heslehurst N et al. A nationally representative study of maternal obesity in England. Int J Obes. 2010
- RCOG Green-top Guideline No. 37a: Reducing the Risk of VTE in Pregnancy and Postpartum (2015)